Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Bio-Rad Laboratories- Inc. (BIO)

298.32 -1.52 (-0.51%)

06-22 16:02

Open:

301.34

Pre. Close:

299.84

High:

301.34

Low:

297.41

Volume:

130,426

Market Cap:

8853M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

302.193 - 303.867

303.867 - 305.227

Low:

292.167 - 294.567

294.567 - 296.518

Close:

296.292 - 299.86

299.86 - 302.759

Technical analysis  (as of: 2018-06-22 4:28:43 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 355.49     One year: 415.22

Support:

Support1: 291.14    Support2: 282.97

Resistance:

Resistance1: 304.36    Resistance2: 355.49

Pivot:

299.09

Moving Averages:

MA(5): 299.55     MA(20): 296.45

MA(100): 267.01     MA(250): 248.41

MACD:

MACD(12,26): 5.63     Signal(12,26,9): 6.73

%K %D:

%K(14,3): 67.67     %D(3): 70.33

RSI:

RSI(14): 62.06

52-Week:

High: 304.36  Low: 208.95  Change(%): 35.4

Average Vol(K):

3-Month: 14722  10-Days 12453

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
BIO has closed below upper band by 44.6%. Bollinger Bands are 51.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to BIO's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-05-30T20:02:00-04:00
Bio-Rad to Present at Jefferies 2018 Global Healthcare Conference on June 5

2018-05-08T22:57:17-04:00
Bio-Rad Laboratories (BIO) Q1 2018 Results - Earnings Call Transcript

2018-05-08T17:57:12-04:00
Bio-Rad Labs beats by $0.10, beats on revenue

2018-05-08T16:25:00-04:00
Bio-Rad Reports First Quarter 2018 Financial Results

2018-05-07T17:35:34-04:00
Notable earnings after Tuesday's close

2018-04-18T16:24:00-04:00
Bio-Rad to Report First-Quarter 2018 Financial Results

2018-03-22T07:40:27-04:00
Bio-Rad receives non-compliance notice from NYSE over 10-K delay

2018-03-22T07:00:00-04:00
Bio-Rad Laboratories, Inc. Receives Expected NYSE Notice Regarding Late Form 10-K Filing

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Medical Equipment Supplies Distribution

Shares Out. (M)

29.80

Shares Float (M)

24.08

% Held by Insiders

% Held by Institutions

59.10

Shares Short (K)

650

Shares Short Prior Month (K)

593

Stock Financials

EPS

4.160

EPS Est. Current Year

2.710

EPS Est. Next Year

4.500

EPS Est. Next Quarter

1.730

Forward EPS

7.410

Book Value (p.s.)

2.020

PEG Ratio

1.31

Profit Margin

33.52

Operating Margin

7.45

Return on Assets (ttm)

14.2

Return on Equity (ttm)

20.1

Qtrly Rev. Growth

10.3

Gross Profit (p.s.)

19.387

Sales Per Share

EBITDA (p.s.)

4.151

Qtrly Earnings Growth

5191.00

Operating Cash Flow (M)

200.43

Levered Free Cash Flow (M)

52.33

atoplab.com

Valuation

P/E

72.07

P/E Growth Ratio

P/BV

148.43

P/S

99473480.00

P/CF

44.59

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.